GSTM1 and anemia (phenotype): The objective of our study was to analyze the risk factors for early severe anaemia, defined as Hb level ≤8 g/dL in the first six months after ART initiation, and, in particular, to examine if AZT could be safely prescribed to patients who initiate ART when they have baseline severe anaemia.